APA ציטוט

Cavagna, P., Sarfati, L., Roos-Weil, D., Leblond, V., Tilleul, P., & Bellanger, A. (2018). 4CPS-136 Are cardiovascular adverse events with ibrutinib well considered? Eur J Hosp Pharm.

Citação norma Chicago

Cavagna, P., L. Sarfati, D. Roos-Weil, V. Leblond, P. Tilleul, and A. Bellanger. "4CPS-136 Are Cardiovascular Adverse Events With Ibrutinib Well Considered?" Eur J Hosp Pharm 2018.

ציטוט MLA

Cavagna, P., et al. "4CPS-136 Are Cardiovascular Adverse Events With Ibrutinib Well Considered?" Eur J Hosp Pharm 2018.